Product NDC: | 0722-7183 |
Proprietary Name: | Mecamylamine Hydrochloride |
Non Proprietary Name: | Mecamylamine Hydrochloride |
Active Ingredient(s): | 2.5 mg/1 & nbsp; Mecamylamine Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0722-7183 |
Labeler Name: | Nexgen Pharma, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA204054 |
Marketing Category: | ANDA |
Start Marketing Date: | 20130319 |
Package NDC: | 0722-7183-01 |
Package Description: | 100 TABLET in 1 BOTTLE (0722-7183-01) |
NDC Code | 0722-7183-01 |
Proprietary Name | Mecamylamine Hydrochloride |
Package Description | 100 TABLET in 1 BOTTLE (0722-7183-01) |
Product NDC | 0722-7183 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Mecamylamine Hydrochloride |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20130319 |
Marketing Category Name | ANDA |
Labeler Name | Nexgen Pharma, Inc. |
Substance Name | MECAMYLAMINE HYDROCHLORIDE |
Strength Number | 2.5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Autonomic Ganglionic Blocker [EPC],Decreased Autonomic Ganglionic Activity [PE] |